3.65
Finanzdaten der Fulcrum Therapeutics Inc-Aktie (FULC)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Operating Expenses |
32.11%
29.31
|
22.19 | 22.69 | 21.86 | 19.82 |
| Operating Income/Loss |
32.11%
-29.31
|
-22.19 | -22.69 | -21.86 | -19.82 |
| Net Income/Loss |
38.58%
-26.18
|
-18.89 | -20.33 | -19.59 | -17.30 |
| Basic Average Shares |
0.06%
76.26
|
76.22 | - | 62.60 | 62.54 |
| Diluted Average Shares |
0.06%
76.26
|
76.22 | - | 62.60 | 62.54 |
| Basic Earnings Per Share |
36.00%
-0.34
|
-0.25 | - | -0.31 | -0.28 |
| Diluted Earnings Per Share |
36.00%
-0.34
|
-0.25 | - | -0.31 | -0.28 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):